569 related articles for article (PubMed ID: 26384160)
1. Rate-control treatment and mortality in atrial fibrillation.
Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Rate-Control Treatment in Patients With Atrial Fibrillation and Heart Failure - A Nationwide Cohort Study.
Yu HT; Yang PS; Lee H; You SC; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B
Circ J; 2018 Feb; 82(3):652-658. PubMed ID: 29142156
[TBL] [Abstract][Full Text] [Related]
3. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
Olshansky B; Rosenfeld LE; Warner AL; Solomon AJ; O'Neill G; Sharma A; Platia E; Feld GK; Akiyama T; Brodsky MA; Greene HL;
J Am Coll Cardiol; 2004 Apr; 43(7):1201-8. PubMed ID: 15063430
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.
Bosch NA; Rucci JM; Massaro JM; Winter MR; Quinn EK; Chon KH; McManus DD; Walkey AJ
Chest; 2021 Apr; 159(4):1452-1459. PubMed ID: 33619010
[TBL] [Abstract][Full Text] [Related]
5. Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease.
You SC; An MH; Yoon D; Ban GY; Yang PS; Yu HT; Park RW; Joung B
Heart Rhythm; 2018 Dec; 15(12):1825-1832. PubMed ID: 30509364
[TBL] [Abstract][Full Text] [Related]
6. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
[TBL] [Abstract][Full Text] [Related]
7. Rate control in atrial fibrillation: many questions still unanswered.
Van Gelder IC; Hobbelt AH; Mulder BA; Rienstra M
Circulation; 2015 Oct; 132(17):1597-9. PubMed ID: 26384161
[No Abstract] [Full Text] [Related]
8. Rate control at least as effective as rhythm control for AF patients.
Geriatrics; 2002 May; 57(5):63. PubMed ID: 12040594
[No Abstract] [Full Text] [Related]
9. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.
Badheka AO; Marzouka GR; Rathod AD; Patel NJ; Myerburg RJ; Mitrani RD
Am J Cardiol; 2013 Jun; 111(12):1759-63. PubMed ID: 23540545
[TBL] [Abstract][Full Text] [Related]
10. Rate control in atrial fibrillation.
Van Gelder IC; Rienstra M; Crijns HJ; Olshansky B
Lancet; 2016 Aug; 388(10046):818-28. PubMed ID: 27560277
[TBL] [Abstract][Full Text] [Related]
11. Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.
Allen LaPointe NM; Governale L; Watkins J; Mulgund J; Anstrom KJ
Am Heart J; 2007 Nov; 154(5):893-8. PubMed ID: 17967595
[TBL] [Abstract][Full Text] [Related]
12. Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?
Al-Khatib SM; Shaw LK; Lee KL; O'Connor C; Califf RM
Am J Cardiol; 2004 Sep; 94(6):797-800. PubMed ID: 15374794
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
Lévy S
Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
[TBL] [Abstract][Full Text] [Related]
14. Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study.
Walkey AJ; Evans SR; Winter MR; Benjamin EJ
Chest; 2016 Jan; 149(1):74-83. PubMed ID: 26270396
[TBL] [Abstract][Full Text] [Related]
15. Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study.
Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Chiang CE; Chen SA
Can J Cardiol; 2014 Oct; 30(10):1190-5. PubMed ID: 25262860
[TBL] [Abstract][Full Text] [Related]
16. Impact of treatment crossovers on clinical outcomes in the rate and rhythm control strategies for atrial fibrillation: Insights from the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) trial.
Maan A; Zhang Z; Qin Z; Wang Y; Dudley S; Dabhadakar K; Refaat M; Mansour M; Ruskin JN; Heist EK
Pacing Clin Electrophysiol; 2017 Jul; 40(7):770-778. PubMed ID: 28543286
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of a contemporary sample of patients with atrial fibrillation taking digoxin: results from the AFBAR study.
Rodríguez-Mañero M; Otero-Raviña F; García-Seara J; Zugaza-Gurruchaga L; Rodríguez-García JM; Blanco-Rodríguez R; Turrado Turrado V; Fernández-Villaverde JM; Vidal-Pérez RC; González-Juanatey JR;
Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):890-7. PubMed ID: 25443813
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.
Bedford J; Drikite L; Corbett M; Doidge J; Ferrando-Vivas P; Johnson A; Rajappan K; Mouncey P; Harrison D; Young D; Rowan K; Watkinson P
Health Technol Assess; 2021 Nov; 25(71):1-174. PubMed ID: 34847987
[TBL] [Abstract][Full Text] [Related]
19. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM
Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic control of heart rate in atrial fibrillation.
Falk RH
Cardiol Clin; 1996 Nov; 14(4):521-36. PubMed ID: 8950054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
